Feasibility and safety of outpatient radiofrequency catheter ablation procedures for atrial fibrillation by Haegeli, L M et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2010
Feasibility and safety of outpatient radiofrequency catheter ablation
procedures for atrial fibrillation
Haegeli, L M; Duru, F; Lockwood, E E; Lüscher, T F; Sterns, L D; Novak, P G; Leather, R A
Abstract: INTRODUCTION: Percutaneous catheter ablation for atrial fibrillation (AF) is a procedure
performed typically in an inpatient setting. The feasibility and safety of catheter ablation in patients
with paroxysmal and persistent AF were evaluated on an outpatient basis. METHODS: 230 AF ablation
procedures were performed in 206 patients (74% male; mean age 56+/-9 years). Patients were admitted
to the hospital outpatient facility in the morning for the AF ablation procedure on the same day. The
ablation strategy consisted of wide area circumferential lines around both ipsilateral pulmonary veins.
After monitoring in the outpatient service, patients were discharged on the same day, if they were clinically
stable. RESULTS: Mean procedure time was 201+/-31 min. Major complications occurred in seven
patients (3%). One patient (0.4%) suffered a minor stroke and six patients had pericardial tamponade
requiring percutaneous drainage. Patients could be discharged on the same day following 205 (89%)
procedures. Among the 148 patients whose clinical outcome was assessed at 6 months, 127 (86%) had
a reduction of the total symptomatic AF episodes, compared to pre-ablation, with a complete lack of
symptoms in 101 patients (68%). CONCLUSION: Catheter ablation of AF on the day of admission is
feasible and safe with a low risk of complications. The vast majority of the patients can be discharged
on the same day.
DOI: 10.1136/pgmj.2009.092510
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-30933
Accepted Version
Originally published at:
Haegeli, L M; Duru, F; Lockwood, E E; Lüscher, T F; Sterns, L D; Novak, P G; Leather, R A (2010).
Feasibility and safety of outpatient radiofrequency catheter ablation procedures for atrial fibrillation.
Postgraduate Medical Journal, 86(1017):395-398. DOI: 10.1136/pgmj.2009.092510
2nd Revision Manuscript ID# POSTGRADMEDJ/2009/092510                     Feb 11, 2010 
 
Original article 
Feasibility and Safety of Outpatient Radiofrequency Catheter 
Ablation Procedures for Atrial Fibrillation 
Short title: Outpatient Ablation of AF 
 
Laurent M. Haegeli,* ‡ Firat Duru,†‡ Evan E. Lockwood,* Thomas F. Lüscher,† 
Laurence D. Sterns,* Paul G. Novak,* and Richard A. Leather*  
 
From the*Department of Cardiology, Royal Jubilee Hospital, Victoria, British Columbia, 
Canada and †Cardiology, Cardiovascular Center, University Hospital Zurich, Switzerland 
 
Conflict of interest: none 
Word count excluding title, abstract, tables, references: 2186 
 
 
 
Correspondence: 
Laurent M. Haegeli, M.D. 
Cardiology, Cardiovascular Center 
University Hospital Zurich 
Rämistrasse 100 
CH-8091 Zurich, Switzerland  
Tel.  +41 (0)44 255 20 99 
Fax +41 (0)44 255 44 01 
E-mail: laurent.haegeli@usz.ch 
 
‡ Drs Haegeli and Duru contributed equally to this article and are shared first authors. 
Haegeli et al. Outpatient Ablation of AF 
Abstract: 
Introduction: Percutaneous catheter ablation for atrial fibrillation (AF) is a procedure 
performed typically in an inpatient setting. We evaluated the feasibility and safety of 
catheter ablation in patients with paroxysmal and persistent AF on an outpatient basis.  
Methods: 230 AF ablation procedures were performed in 206 patients (74% male; mean 
age 56±9 years). Patients were admitted to the hospital outpatient facility in the morning 
for the AF ablation procedure on the same day. The ablation strategy consisted of wide-
area circumferential lines around both ipsilateral pulmonary veins. After monitoring in 
the outpatient service, patients were discharged on the same day, if they were clinically 
stable. 
Results: Mean procedure time was 201±31 minutes. Major complications occurred in 7 
patients (3%). One patient (0.4%) suffered a minor stroke and 6 patients had pericardial 
tamponade requiring percutaneous drainage. Patients could be discharged on the same 
day following 205 (89%) procedures. Among the 148 patients whose clinical outcome 
was assessed at 6 months, 127 (86%) had a reduction of the total symptomatic AF 
episodes, compared to pre-ablation, with a complete lack of symptoms in 101 patients 
(68%). 
Conclusion: Catheter ablation of AF on the day of admission is feasible and safe with a 
low risk of complications. The vast majority of the patients can be discharged on the 
same day.  
Keywords: Atrial fibrillation, catheter ablation, outpatient, anticoagulation, safety, 
outcome 
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Glossary of abbreviations: 
AF  Atrial fibrillation 
INR  International normalized ratio 
ACT  Activated clotting time 
LMWH Low molecular weight heparin 
AAD  Antiarrhythmic drug 
LA  Left atrium 
EF  Ejection fraction 
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Introduction: 
In recent years, catheter ablation has been widely performed as an effective treatment in 
patients with symptomatic, drug-resistant AF.  Various ablation strategies have been used 
to achieve a high efficacy for all types of AF. However, the procedure remains to be 
complex and is associated with a relatively high incidence of complications. 
Thromboembolic events, pericardial tamponade, pulmonary vein stenosis, and 
oesophageal injury are among the potential major complications of catheter-based 
radiofrequency ablation of AF and are known to occur 3.9 - 6% of cases. [1, 2, 3] 
Therefore, the procedure is typically performed in an inpatient setting, which includes 
overnight stay after the procedure. 
Catheter ablation has become the treatment of choice for most supraventricular 
arrhythmias as it is safe and promotes cure in the majority of patients. [4, 5, 6] Improved 
catheter and mapping technologies and enhanced clinical expertise favourably influence 
ease and safety of ablation, resulting in an increased trend to perform these procedures on 
an outpatient basis. Arrhythmias, such as atrioventricular nodal reentry tachycardia and 
accessory pathways in patients without associated comorbidities are particularly suited 
for the outpatient ablation procedure. [7, 8, 9] As a result of the reduction in hospital stay, 
procedure-related costs are reduced and the patients return early to work, and therefore, 
outpatient procedures have important economic and occupational impacts. Furthermore, 
from a patient’s perspective, outpatient procedure contributes in early ambulation and 
increased patient comfort. 
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Given the high incidence of AF in the general population, the increasing number of 
ablation procedures for the treatment of this arrhythmia is likely to lead to logistic 
constraints. Some electrophysiology centres attempt same day discharge after AF 
ablation, particularly if the patient’s insurance only covers outpatient procedures. 
However, outpatient ablation for AF is more challenging not only due to the complexity 
of the procedure itself, but also due to the need for anticoagulation prior to and after the 
procedure. By feasibility we meant the practicability of performing catheter ablation 
procedures for patients with atrial fibrillation on an outpatient basis without admission. 
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Methods: 
Study patients: Consecutive patients with symptomatic paroxysmal or persistent AF in 
the absence of a significant structural heart disease undergoing a percutaneous catheter 
ablation procedure at the Royal Jubilee Hospital in Victoria B.C. (Canada) over the time 
period of one and a half year were included in this study. Demographic and clinical data 
were collected prior to the procedure. All patients gave informed consent prior to the 
procedure. 
Ablation procedure: All patients were admitted to the outpatient facility on the morning 
of the procedure and were brought to the electrophysiologic laboratory in a non-sedated 
state. The procedures were started at 8:30 am lasting three to four hours. Three femoral 
vein sheaths were inserted under local anaesthesia. A 6F steerable decapolar 
electrophysiology catheter LivewireTM (St. Jude Medical Inc., St. Paul, MN, USA) was 
placed into the coronary sinus. After double transseptal puncture performed by a BRKTM 
transseptal needle (St. Jude Medical Inc., St. Paul, MN, USA), a 5F circular decapolar 
catheter Supreme Spiral SCTM (St. Jude Medical Inc., St. Paul, MN, USA) and a 7F non-
irrigated 4 mm tip bi-directional ablation catheter RF ConductrTM MC (Medtronic Inc., 
Minneapolis, MN, USA) were passed transseptally through two 8F transseptal guiding 
introducers SwartzTM SL1TM  (St. Jude Medical Inc., St. Paul, MN, USA). The catheter 
ablation was performed using radiofrequency energy under Ensite NavXTM mapping 
system (St. Jude Medical Inc., St. Paul, MN, USA) guidance.  
The ablation strategy consisted of continuous wide-area circumferential lines around both 
ipsilateral pulmonary veins. Lesions were delivered for 30 seconds, using RF energy up  
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to 35 Watts for a maximum target temperature of 58° Celsius. For patients with persistent 
AF, additional linear lesions were performed: a left atrial roof line connecting both upper 
left and right pulmonary veins and a left atrial isthmus line between the mitral valve 
annulus and the left inferior pulmonary vein. The additional left atrial lines were not 
routinely mapped and checked for conduction block and no ablation within the coronary 
sinus was performed. The endpoint of the procedure in both paroxysmal and persistent 
AF patients was electrical isolation of all pulmonary veins, which was assessed using the 
circular spiral catheter. In patients with persistent AF an electrical cardioversion was 
required to terminate AF. Atrial tachycardia or atrial flutter developing during the 
procedure were not mapped and only ablated if clinical recurrence was present. The 
procedure was performed under conscious sedation using midazolam and fentanyl. After 
the procedure the patients were monitored for at least five hours and discharged if they 
were stable on the same day. The minimum bedrest regime was four hours. No routine 
echocardiogram was performed. All patients were primarily eligible for discharge on the 
same day prior to 8 pm. Local patients were discharged home. Patients from remote areas 
were asked to stay overnight in-town either in a local hotel or in a relative’s home. 
Patients with no accompany were allowed to stay overnight. There were no other 
predefined criteria to keep patients overnight. The outpatient facility was staffed 
overnight and could accommodate outpatient patients if overnight observation and care 
were required. 
Anticoagulation Strategy: Warfarin was discontinued three days prior to the procedure to 
allow international normalized ratio (INR) to drop in a subtherapeutic range the day of 
the procedure (INR<2.0). After insertion of the transseptal catheters, therapeutic 
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anticoagulation was initiated with a bolus of intravenous heparin (100 IU/kg 
bodyweight). Activated clotting time (ACT) was monitored in 30 minute intervals 
followed by additional boluses of heparin to keep the ACT levels between 250 and 300 
seconds. The sheaths were remove at the end of the procedure if ACT was below 180 
seconds. No protamin was given to reverse heparin. Oral anticoagulation was resumed on 
the same day of the procedure for at least 3 months. Patients who presented with 
persistent AF were administered subcutaneous low molecular weight heparin (LMWH) 
until an INR value above 2.0 was reached. Aspirin 81 mg/day was given to all patients 
for the four weeks following the procedure. Transoesophageal echocardiogram was 
performed in patients with persistent AF and subtherapeutic or absent anticoagulation 
prior to ablation, but otherwise was not a prerequisite. 
Data analysis: All patients admitted to the outpatient facility for the purpose of catheter 
ablation of AF were entered into our database. Information was collected on patient and 
clinical demographics, procedure characteristics, periprocedural complications and 
clinical results at follow-up including rhythm control status and late complicatons using a 
patient assessment form at 6 months after the intervention. Six month success was 
defined as complete lack of symptoms from atrial fibrillation regardless the intake of 
antiarrhythmic  drugs.
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Results: 
Patient and clinical demographics: A total of 230 catheter ablation procedures were 
performed consecutively on 206 patients with AF (table 1). The patients could be 
discharged on the same day following 205 (89%) of these procedures (figure 1). The 
remaining were kept inpatient overnight either due to major complications listed below, 
minor groin bleeding requiring prolonged compression and bed rest in 10 patients (4.3%), 
or due to late completion of the procedure or reduced overall well-being from conscious 
sedation. There were no differences of the same day discharge rate whether the patients 
had paroxysmal or persistent AF. 
Procedural characteristics and periprocedural complications: Major complications 
occurred in 7 patients (3%). One patient (0.4%) suffered a minor stroke immediately after 
the procedure with no long term deficits. No late peripheral or cerebral thromboembolic 
events were observed at the 6 month follow-up. Six procedures were complicated at the 
end of the intervention by a pericardial effusion requiring percutaneous drainage. None of 
the procedures were complicated by vascular access complications requiring transfusion 
or surgical interventions (table 2).  
Clinical results: Among the 148 patients whose clinical outcome was assessed at 6 
months, 127 (86%) had a reduction of the total symptomatic AF episodes, compared to 
pre-ablation, with a complete lack of symptoms in 101 patients (68%) and partial success 
(defined  as >90% improvement in symptoms) in the remaining 26 (18%) (figure 2). 20 
patients (16%) out of 127 patients with a reduction of the total symptomatic AF episodes 
needed a repeat procedure on an outpatient basis. The remaining patients were lost to 
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follow-up and could not be reached because of the large distance between the ablation 
centre and the remote areas where the patients were referred from within Canada. No late 
complications were observed. 
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Discussion: 
Our study showed that catheter ablation of AF on an outpatient basis in a single centre 
seems to be feasible and safe with risk of complications as low as for inpatient AF 
ablation. [1, 2, 3] Among 230 patients admitted for paroxysmal and persistent AF 
ablation, 89% could be discharged on the same day following the procedure. Major 
complications occurred in seven patients (3%) requiring hospital admission. Eighteen 
patients were admitted to stay overnight because of minor groin bleeding, late completion 
of the procedure or reduced well-being after deep conscious sedation. There were no 
differences for patients with paroxysmal or persistent AF in terms of procedure time, 
complication rate and same day discharge rate. Among the patients assessed at 6 month 
follow-up, 68% remained symptom free from atrial fibrillation.  
Catheter ablation on an outpatient basis is an established safe treatment of 
supraventricular tachyarrhythmias and reports on the feasibility and safety are available. 
[7, 8] To the best of our knowledge, this study reports for the first time data on the 
feasibility and safety of outpatient ablation for paroxysmal or persistent AF.  
Same day discharge allows not only cost reduction, but renders substantial logistic 
benefits for the clinic. A majority of patients do not require a hospital bed after the 
procedure. Furthermore, from a patient’s perspective, outpatient procedure contributes in 
early ambulation, increased patient comfort and early return to work. Therefore, 
outpatient procedures have important economic and occupational impacts. The use of our 
outpatient model for AF catheter ablation saved eighty-nine overnight hospital 
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accommodations per hundred patients treated and primarily admitted for a same day 
discharge procedure. 
AF ablation is a challenging intervention because of the risk for potential of 
thromboembolic events on one hand, and bleeding complications due to periprocedural 
anticoagulation on the other. [1, 2, 3] There are published guidelines for anticoagulation 
in patients undergoing AF ablation. [10, 11] However, there is a great variability in pre- 
and post-procedure anticoagulation protocols, and no unified strategy exists to date. Most 
centers discontinue warfarin and use subcutaneous LMWH or intravenous heparin to 
bridge anticoagulation before and after ablation. [12, 13, 14] However, bridging 
anticoagulation may increase the risk of bleeding and thrombosis, especially early after 
ablation. [15] Prior studies have indicated a 0.5% to 7 % risk of stroke and transient 
ischemic episodes after radiofrequency ablation. [1, 2, 3, 16, 17, 18, 19, 20, 21] Oral et al. 
[12] described a strategy in which LMWH was given prior to and after the intervention as 
bridging to warfarin showing 7 thromboembolic events in a group of 755 patients (0.9%). 
The present study showed a low risk of embolic events, with only one case of minor 
stroke (0.4%) occurring following the procedure. The average maximum intra-procedural 
ACT was 266 seconds. However, the thromboembolic events in our group were low. At 
the time when the study was performed non-irrigated ablation catheters were still used for 
AF catheter ablation, but since then irrigated ablation catheters are widely used with the 
advantage of deep lesion creation and decreased thrombosis rates. No routine 
echocardiogram was performed in all, unless AF catheter ablation was complicated 
and/or there were signs for pericardial effusion, which occurred intraprocedurally or 
immediately postprocedurally. 
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Catheter ablation for AF and discharge on the day of admission seems to be feasible for 
most patients. However, given the complexity of the procedure, outpatient AF ablation 
services should allow extended observation period or overnight stay for the occasional 
patient whose clinical condition is not suitable for discharge. Having this possibility on 
hold, the strategy of AF ablation on the day of admission with the intention for same day 
discharge can be applied for most patients.  
Limitations: This is an observational cohort study, and is not a prospective, randomised 
trial. In the absence of a direct randomised comparison of same day discharge with 
overnight hospital stay, only limited conclusions regarding the safety of an outpatient AF 
ablation procedure can be made. No complete data on readmission to other hospitals for 
minor or major complications after discharge were available as the majority of the 
patients were referred from remote areas in Canada. In addition, the clinical outcome was 
assessed based on symptoms reported by the patients only, and therefore, the reliability of 
the presented data on outcome is limited due to known difficulties of survey-based 
studies. Further prospective, randomised trials of patients referred for AF catheter 
ablation comparing an inpatient and an outpatient procedure setting are required. 
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Main messages 
 Catheter ablation is an established treatment in patients with symptomatic AF and 
is performed mostly in an inpatient setting due to technique’s complexity and 
potential complications. 
 An outpatient setting is an attractive alternative in light of increasing numbers of 
procedures leading to logistic and health-economical constraints. 
 Outpatient ablation of AF may contribute to patient comfort and early ambulation. 
 This paper shows that catheter ablation of AF performed in an outpatient setting is 
feasible and safe with a low risk of complications. 
 
Current research questions 
 What are the complication rates of outpatient ablation of AF as compared to 
inpatient ablation ? 
 What are the economical and occupational impacts of the outpatient procedure ? 
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Conclusion: 
Catheter ablation of AF on the day of admission seems to be feasible and safe with a low 
risk of complications. The majority of the patients may be discharged on the same day. 
However, it needs to be investigated in prospective randomised studies if catheter 
ablation of AF offers a safe alternative strategy to the inpatient procedure in different 
patient groups with AF. 
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Table 1: Patient characteristics 
 
 n=206 
Age 569.3 
Gender (male) 152 (74%) 
Type of AF 
 Paroxysmal AF 
 Persistent AF 
 
 
171 (83%) 
35 (17%) 
Number of AF episodes per month 1416 
History of AF (yrs) 7.66.5 
Number of AAD 1.50.99 
Transthoracic echocardiography 
 LA size (mm) 
 EF (%) 
 
39.96.4 
59.24.7% 
 
AAD=antiarrhythmic drug, LA=left atrium, EF=ejection fraction 
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Table 2: Procedural data 
 
 n=230 
 
Average procedure time (minutes) 
 paroxysmal AF patients 
 persistent AF patients 
 
Fluoroscopy time (minutes) 
 
20131 
21430 
19731 
 
42.510.3 
 paroxysmal AF patients 
 persistent AF patients 
Average heparin dose (IU)  
4210 
4611 
135193532 
Average minimum ACT (seconds) 
Average maximum ACT (seconds) 
Pulmonary vein isolation 
20923 
26638 
225 (98%) 
Major complications 
 Minor stroke with no long-term disability  
 Pericardial tamponade 
 Vascular access complications 
 
1 
6 
none  
 
ACT=activated clotting time, IU=international units 
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Figure 1: Same day discharge rate 
 
205
25
Same day discharge
No same day discharge
 
Figure 2: Outcome at 6 month follow-up 
21
101
26
127
No Success
Complete Success
Partial success (>90%)
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